CTRI/2021/01/030777
Not yet recruiting
未知
Prospective pilot study to assess effectiveness of novel forehead knuckle tapping method in localisation of better or worse hearing ear as compared to conventional tuning fork testing
Dr Prem Sagar0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Prem Sagar
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients giving consent to participate in the study and to tap on the forehead
Exclusion Criteria
- •Patients refusing to give consent to tap on forehead and Patients who are unable to comprehend or follow commands given by doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Study to evaluate the efficacy of OnabotulinumtoxinA in migraineEUCTR2017-002866-38-ITIRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO42
Not yet recruiting
Not Applicable
study to test the effect of music on quality of life of cancer patients undergoing chemotherapyHealth Condition 1: D499- Neoplasm of unspecified behavior of unspecified siteCTRI/2023/03/050509Apollo Proton Cancer Centre
Not yet recruiting
Not Applicable
To Investigate whether resveratrol and copper can reduce the amount of virus load in patients with Chronic Hepatitis B and C virus infectioHealth Condition 1: B191- Unspecified viral hepatitis BCTRI/2023/05/053055Tata Memorial Hospital
Active, not recruiting
Not Applicable
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]Non Familial Chylomicronemia Syndrome (Non-FCS)EUCTR2012-000872-40-CZovartis Pharma Services AG60
Completed
Phase 3
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infantsJPRN-UMIN000015061agano Children's Hospital10